Please try another search
Mauna Kea Technologies SA develops and markets medical devices in Europe and internationally. The company offers range of medical devices, which includes gastroenterology, pulmonology, urology, and drug development. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.
Name | Age | Since | Title |
---|---|---|---|
Christopher D. McFadden | - | 2008 | Independent Director |
Alexandre Loiseau | - | 2000 | Co-Founder, CEO & Chairman |
Jacquelien Ten Dam | - | 2020 | Independent Director |
Molly K. O'Neill | 59 | 2018 | Independent Director |
Claire Biot | - | 2020 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review